Lipids and Women's Health: Recent Updates and Implications for Practice

Area of Science:

• Cardiovascular disease and diabetes risk factor management in women's health.

Background:

• Obstetrician/gynecologists often act as primary care physicians for women.
• Current lipid disorder screening guidelines for women vary, with some recommending age 45, while others suggest age 21 for early cardiovascular disease risk detection.

Purpose of the Study:

• To provide an overview of cardiovascular risk factor optimization for women's health practitioners.
• To guide the identification and treatment of patients at risk for cardiovascular disease and diabetes.

Main Methods:

• Discussion of screening benefits for specific conditions: familial hypercholesterolemia (FH), metabolic syndrome (MetS), polycystic ovary syndrome, and hypertriglyceridemia.
• Review of practical lipid management approaches and drug safety concerns.

Main Results:

• Early screening (age 21) can identify individuals at risk for cardiovascular disease, enabling timely lifestyle interventions or statin therapy.
• Early recognition of FH allows for risk-reducing interventions and identification of affected relatives.
• Detecting metabolic variables like MetS and hypertriglyceridemia can enhance focus on lifestyle modifications.

Conclusions:

• Adopting earlier lipid screening (age 21) aligns with updated guidelines for comprehensive cardiovascular risk management in women.
• Targeted screening and management strategies are crucial for women with FH, MetS, PCOS, or hypertriglyceridemia to prevent premature cardiovascular events and diabetes.